27-hydroxycholesterol has been researched along with Pneumonia, Viral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adami, M; Brambilla, P; Caccia, C; Cavalli, R; Civra, A; Giacobone, C; Lembo, D; Leoni, V; Marcello, A; Milan Bonotto, R; Nascimento Alves, L; Poli, G; Rajasekharan, S | 1 |
1 other study(ies) available for 27-hydroxycholesterol and Pneumonia, Viral
| Article | Year |
|---|---|
The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients.
Topics: Aged; Animals; Antiviral Agents; Betacoronavirus; Biomarkers; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Female; Hep G2 Cells; Humans; Hydroxycholesterols; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells | 2020 |